Chronic fatigue syndrome
ICD-10 G93.3 · ICD-11 8E49

Treatment of Chronic Fatigue Syndrome with Comorbid Depression, Anxiety & Mood Disorders

Chronic fatigue syndrome (CFS/ME) frequently presents alongside depression, anxiety, and other mood disorders. This co-occurrence is common — affecting an estimated 25–40% of CFS patients — and shapes the clinical approach to treatment.

Clinical scenario

This protocol addresses patients with chronic fatigue syndrome who have comorbid depression, anxiety, or mood disorders. These conditions compound the core features of CFS, affecting sleep, pain experience, and functional capacity, and are a key consideration when selecting a management strategy.

Treatment approach

Antidepressant therapy is a key component of the approach for this population. Specific classes of antidepressants have shown relevance for CFS patients with co-existing mood and sleep disturbance. The full structured regimen — including which agents apply and how — is available in the complete protocol.

Clinical goals

The target outcomes for this protocol are improvement in depression and anxiety symptoms, improved sleep quality, and reduced pain — typically assessed at 3 to 4 weeks from initiation of therapy.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/bph.13702

Around 25–40% of CFS patients can be expected to have comorbid anxiety and depression.
CFS/ME patients are frequently prescribed antidepressants to treat secondary depression or mood swings, and tricyclic antidepressants may be prescribed in low doses to increase sleep quality and reduce pain.
Other tricyclics (doxepin, desipramine, nortriptyline, clomipramine and imipramine) improve sleep and relieve pain, although it can take 3 to 4 weeks for symptoms to improve.
The widely-used antidepressants (fluoxetine, sertraline, and paroxetine) known as selective serotonin-reuptake inhibitors (SSRIs) may be helpful for CFS/ME subjects who experience significant chronic neuropathic pain, fibromyalgia, anxiety/depression and other mood disorders.
View source ↗